Ftse Mib
34.293,80
-0,24%
DAX
18.502,81
-0,52%
S&P 500
5.631,22
0,00%
NASDAQ
18.472,57
0,00%
Bitcoin
63.813,15
-1,60%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AbCellera Biologics Inc (ABCL) AbCellera Biologics Inc (ABCL) Notizie

ABCL

AbCellera Biologics (ABCL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL
DataOraFonteTitoloSimboloCompagnia
17/09/202112:37TipRanksFDA Extends EUA for AbCellera’s Bamlanivimab; Shares Rally 19.8%NASDAQ:ABCLAbCellera Biologics Inc
16/09/202122:15Business WireEmergency Use Authorization of AbCellera-Discovered Bamlanivimab Administered with Etesevimab Expanded by the FDA to Include Post-Exposure Prophylaxis for the Prevention of COVID-19NASDAQ:ABCLAbCellera Biologics Inc
16/09/202108:39TipRanksAbCellera Collaborates with Moderna; Shares Rise 7.1%NASDAQ:ABCLAbCellera Biologics Inc
15/09/202123:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ABCLAbCellera Biologics Inc
15/09/202122:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABCLAbCellera Biologics Inc
15/09/202122:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABCLAbCellera Biologics Inc
15/09/202115:00Business WireAbCellera Announces Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA MedicinesNASDAQ:ABCLAbCellera Biologics Inc
13/09/202115:00Business WireAbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value TargetsNASDAQ:ABCLAbCellera Biologics Inc
10/09/202122:17Business WireAbCellera to Present Virtually at the BofA Securities – Tech Solutions for Drug Discovery ConferenceNASDAQ:ABCLAbCellera Biologics Inc
13/08/202122:33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABCLAbCellera Biologics Inc
12/08/202122:05Business WireAbCellera Reports Q2 2021 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
04/08/202113:00Business WireEQRx and AbCellera Announce Collaboration to Accelerate the Advancement of New Innovative MedicinesNASDAQ:ABCLAbCellera Biologics Inc
03/08/202112:00Business WireTachyon and AbCellera Collaborate to Develop Novel Antibody Therapeutic Targeting TGF-β Superfamily Member for the Treatment of CancerNASDAQ:ABCLAbCellera Biologics Inc
22/07/202122:05Business WireAbCellera to Report Second Quarter 2021 Financial Results on August 12, 2021NASDAQ:ABCLAbCellera Biologics Inc
13/07/202115:00Business WireAbCellera Appoints Neil Berkley as Chief Business OfficerNASDAQ:ABCLAbCellera Biologics Inc
22/06/202115:00Business WireAbCellera Continues Expansion & Strengthens Future Pandemic Preparedness with First-of- its-Kind GMP Manufacturing Facility f...NASDAQ:ABCLAbCellera Biologics Inc
10/06/202123:18Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ABCLAbCellera Biologics Inc
10/06/202123:11Business WireAbCellera Announces Secondary Private Sale of 11.9 Million Common SharesNASDAQ:ABCLAbCellera Biologics Inc
17/05/202122:07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ABCLAbCellera Biologics Inc
15/05/202102:48Business WireCORRECTING and REPLACING AbCellera Reports Q1 2021 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
13/05/202122:05Business WireAbCellera Reports Q1 2021 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
11/05/202122:05Business WireAbCellera to Present Virtually at Berenberg Conference on May 18, 2021NASDAQ:ABCLAbCellera Biologics Inc
06/05/202115:00Business WireAbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic RetinopathyNASDAQ:ABCLAbCellera Biologics Inc
04/05/202112:30Business WireNew AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical TrialsNASDAQ:ABCLAbCellera Biologics Inc
29/04/202122:10Business WireAbCellera Breaks Ground on Global Headquarters in Vancouver and Expects to Hire Hundreds of Scientific and Tech ProfessionalsNASDAQ:ABCLAbCellera Biologics Inc
28/04/202122:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ABCLAbCellera Biologics Inc
21/04/202122:05Business WireAbCellera to Report First Quarter 2021 Financial Results on May 13, 2021NASDAQ:ABCLAbCellera Biologics Inc
14/04/202122:05Business WireAbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery CollaborationNASDAQ:ABCLAbCellera Biologics Inc
12/04/202122:05Business WireAbCellera to Present Virtually at Upcoming Investor ConferencesNASDAQ:ABCLAbCellera Biologics Inc
05/04/202120:00Business WirePublished Peer-Reviewed Data Demonstrate Bamlanivimab’s High Potency Against SARS-CoV-2 & Support its Use as a Foundational...NASDAQ:ABCLAbCellera Biologics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL

La tua Cronologia

NYSE
STZ.B
Constellation Brands
NASDAQ
LMNX
Luminex
TSXV
OCI
Orecap Invest
NASDAQ
GAMC
Golden Arrow Merger
EU
CF1
Amundi CAC SBT 15 Net Ze...
NASDAQ
PFIE
Profire Energy
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network